Literature DB >> 24097980

Analysis of hyperekplexia mutations identifies transmembrane domain rearrangements that mediate glycine receptor activation.

Anna Bode1, Joseph W Lynch2.   

Abstract

Pentameric ligand-gated ion channels (pLGICs) mediate numerous physiological processes and are therapeutic targets for a wide range of clinical indications. Elucidating the structural differences between their closed and open states may help in designing improved drugs that bias receptors toward the desired conformational state. We recently showed that two new hyperekplexia mutations, Q226E and V280M, induced spontaneous activity in α1 glycine receptors. Gln-226, located near the top of transmembrane (TM) 1, is closely apposed to Arg-271 at the top of TM2 in the neighboring subunit. Using mutant cycle analysis, we inferred that Q226E induces activation via an enhanced electrostatic attraction to Arg-271. This would tilt the top of TM2 toward TM1 and hence away from the pore axis to open the channel. We also concluded that the increased side chain volume of V280M, in the TM2-TM3 loop, exerts a steric repulsion against Ile-225 at the top of TM1 in the neighboring subunit. We infer that this steric repulsion would tilt the top of TM3 radially outwards against the stationary TM1 and thus provide space for TM2 to relax away from the pore axis to create an open channel. Because the transmembrane domain movements inferred from this functional analysis are consistent with the structural differences evident in the x-ray atomic structures of closed and open state bacterial pLGICs, we propyose that the model of pLGIC activation as outlined here may be broadly applicable across the eukaryotic pLGIC receptor family.

Entities:  

Keywords:  Cys Loop Receptors; Glycine Receptors; Patch Clamp; Receptor Structure-Function; Site-directed Mutagenesis

Mesh:

Substances:

Year:  2013        PMID: 24097980      PMCID: PMC3837120          DOI: 10.1074/jbc.M113.513804

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Ligand-gated ion channels: mechanisms underlying ion selectivity.

Authors:  Angelo Keramidas; Andrew J Moorhouse; Peter R Schofield; Peter H Barry
Journal:  Prog Biophys Mol Biol       Date:  2004-10       Impact factor: 3.667

2.  Quantitative nanoscopy of inhibitory synapses: counting gephyrin molecules and receptor binding sites.

Authors:  Christian G Specht; Ignacio Izeddin; Pamela C Rodriguez; Mohamed El Beheiry; Philippe Rostaing; Xavier Darzacq; Maxime Dahan; Antoine Triller
Journal:  Neuron       Date:  2013-07-24       Impact factor: 17.173

3.  The surface accessibility of the glycine receptor M2-M3 loop is increased in the channel open state.

Authors:  J W Lynch; N L Han; J Haddrill; K D Pierce; P R Schofield
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

4.  Disulphide bridges in globular proteins.

Authors:  J M Thornton
Journal:  J Mol Biol       Date:  1981-09-15       Impact factor: 5.469

5.  Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia.

Authors:  R Shiang; S G Ryan; Y Z Zhu; A F Hahn; P O'Connell; J J Wasmuth
Journal:  Nat Genet       Date:  1993-12       Impact factor: 38.330

Review 6.  Molecular structure and function of the glycine receptor chloride channel.

Authors:  Joseph W Lynch
Journal:  Physiol Rev       Date:  2004-10       Impact factor: 37.312

7.  GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization.

Authors:  Robert J Harvey; Ulrike B Depner; Heinz Wässle; Seifollah Ahmadi; Cornelia Heindl; Heiko Reinold; Trevor G Smart; Kirsten Harvey; Burkhard Schütz; Osama M Abo-Salem; Andreas Zimmer; Pierrick Poisbeau; Hans Welzl; David P Wolfer; Heinrich Betz; Hanns Ulrich Zeilhofer; Ulrike Müller
Journal:  Science       Date:  2004-05-07       Impact factor: 47.728

8.  Mutation of an arginine residue in the human glycine receptor transforms beta-alanine and taurine from agonists into competitive antagonists.

Authors:  S Rajendra; J W Lynch; K D Pierce; C R French; P H Barry; P R Schofield
Journal:  Neuron       Date:  1995-01       Impact factor: 17.173

9.  Startle disease mutations reduce the agonist sensitivity of the human inhibitory glycine receptor.

Authors:  S Rajendra; J W Lynch; K D Pierce; C R French; P H Barry; P R Schofield
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

10.  Decreased agonist affinity and chloride conductance of mutant glycine receptors associated with human hereditary hyperekplexia.

Authors:  D Langosch; B Laube; N Rundström; V Schmieden; J Bormann; H Betz
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more
  16 in total

1.  A Novel Glycine Receptor Variant with Startle Disease Affects Syndapin I and Glycinergic Inhibition.

Authors:  Georg Langlhofer; Natascha Schaefer; Hans M Maric; Angelo Keramidas; Yan Zhang; Peter Baumann; Robert Blum; Ulrike Breitinger; Kristian Strømgaard; Andreas Schlosser; Michael M Kessels; Dennis Koch; Britta Qualmann; Hans-Georg Breitinger; Joseph W Lynch; Carmen Villmann
Journal:  J Neurosci       Date:  2020-04-30       Impact factor: 6.167

2.  Correlating structural and energetic changes in glycine receptor activation.

Authors:  Suzanne Scott; Joseph W Lynch; Angelo Keramidas
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

3.  Allosteric and hyperekplexic mutant phenotypes investigated on an α1 glycine receptor transmembrane structure.

Authors:  Gustavo Moraga-Cid; Ludovic Sauguet; Christèle Huon; Laurie Malherbe; Christine Girard-Blanc; Stéphane Petres; Samuel Murail; Antoine Taly; Marc Baaden; Marc Delarue; Pierre-Jean Corringer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

4.  String method solution of the gating pathways for a pentameric ligand-gated ion channel.

Authors:  Bogdan Lev; Samuel Murail; Frédéric Poitevin; Brett A Cromer; Marc Baaden; Marc Delarue; Toby W Allen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-09       Impact factor: 11.205

5.  Disturbed neuronal ER-Golgi sorting of unassembled glycine receptors suggests altered subcellular processing is a cause of human hyperekplexia.

Authors:  Natascha Schaefer; Christoph J Kluck; Kerry L Price; Heike Meiselbach; Nadine Vornberger; Stephan Schwarzinger; Stephanie Hartmann; Georg Langlhofer; Solveig Schulz; Nadja Schlegel; Knut Brockmann; Bryan Lynch; Cord-Michael Becker; Sarah C R Lummis; Carmen Villmann
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

6.  Exploring the Conformational Impact of Glycine Receptor TM1-2 Mutations Through Coarse-Grained Analysis and Atomistic Simulations.

Authors:  Anil Ranu Mhashal; Ozge Yoluk; Laura Orellana
Journal:  Front Mol Biosci       Date:  2022-06-28

7.  Investigating the Mechanism by Which Gain-of-function Mutations to the α1 Glycine Receptor Cause Hyperekplexia.

Authors:  Yan Zhang; Anna Bode; Bindi Nguyen; Angelo Keramidas; Joseph W Lynch
Journal:  J Biol Chem       Date:  2016-05-18       Impact factor: 5.157

8.  The synthetic cannabinoid dehydroxylcannabidiol restores the function of a major GABAA receptor isoform in a cell model of hyperekplexia.

Authors:  Guichang Zou; Jing Xia; Qianqian Han; Dan Liu; Wei Xiong
Journal:  J Biol Chem       Date:  2019-11-22       Impact factor: 5.157

Review 9.  The impact of human hyperekplexia mutations on glycine receptor structure and function.

Authors:  Anna Bode; Joseph W Lynch
Journal:  Mol Brain       Date:  2014-01-09       Impact factor: 4.041

10.  Disturbances of Ligand Potency and Enhanced Degradation of the Human Glycine Receptor at Affected Positions G160 and T162 Originally Identified in Patients Suffering from Hyperekplexia.

Authors:  Sinem Atak; Georg Langlhofer; Natascha Schaefer; Denise Kessler; Heike Meiselbach; Carolyn Delto; Hermann Schindelin; Carmen Villmann
Journal:  Front Mol Neurosci       Date:  2015-12-22       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.